High-dose IV Vitamin C
When taken by intravenous (IV) infusion, vitamin C can reach much higher levels in the blood than when it is taken by mouth. Studies suggest that these higher levels of vitamin C may cause the death of cancer cells in the laboratory.
A severe deficiency (lack) of vitamin C in the diet causes scurvy, a disease with symptoms of extreme weakness, lethargy, easy bruising, and bleeding. The lack of vitamin C in patients with scurvy makes collagen thinner in texture; when vitamin C is given, collagen becomes thicker again.
There are many conditions that may benefit from IVC therapy: arthritis, Lyme disease, bacterial infections, viral infections, pain after injury, and more.
The National Institutes of Health has published evidence confirming Vitamin C’s anti-cancer properties.
IV Vitamin C is one of the best antiviral agents available, with the ability to neutralize and eliminate a wide range of toxins. Vitamin C will enhance host resistance, greatly augmenting the immune system’s ability to neutralize bacterial and fungal infections.
Cancer patients have reported a pain reduction and better chemotherapy tolerance after receiving high-dose IV vitamin C. Intravenous vitamin C is complementary to most oncologic care so, in most cases, patients may continue their conventional cancer therapies if they choose to.
CAUTION: A small group of patients may have a disorder called G6PD deficiency. These patients should not receive high-dose vitamin C therapy. Therefore, we administer a simple blood test to to rule out this condition before initiating higher doses.